These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 20110752)
1. Absorption, distribution, metabolism and excretion of corifollitropin alfa, a recombinant hormone with a sustained follicle-stimulating activity. van Schanke A; van de Wetering-Krebbers SF; Bos E; Sloot WN Pharmacology; 2010; 85(2):77-87. PubMed ID: 20110752 [TBL] [Abstract][Full Text] [Related]
2. Pharmacologic profiling of corifollitropin alfa, the first developed sustained follicle stimulant. Verbost P; Sloot WN; Rose UM; de Leeuw R; Hanssen RG; Verheijden GF Eur J Pharmacol; 2011 Jan; 651(1-3):227-33. PubMed ID: 21115001 [TBL] [Abstract][Full Text] [Related]
3. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Fauser BC; Mannaerts BM; Devroey P; Leader A; Boime I; Baird DT Hum Reprod Update; 2009; 15(3):309-21. PubMed ID: 19182099 [TBL] [Abstract][Full Text] [Related]
4. Corifollitropin alfa, a long-acting follicle-stimulating hormone agonist for the treatment of infertility. Loutradis D; Drakakis P; Vlismas A; Antsaklis A Curr Opin Investig Drugs; 2009 Apr; 10(4):372-80. PubMed ID: 19337959 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility. Balen AH; Mulders AG; Fauser BC; Schoot BC; Renier MA; Devroey P; Struijs MJ; Mannaerts BM J Clin Endocrinol Metab; 2004 Dec; 89(12):6297-304. PubMed ID: 15579793 [TBL] [Abstract][Full Text] [Related]
7. Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction. Croxtall JD; McKeage K BioDrugs; 2011 Aug; 25(4):243-54. PubMed ID: 21815699 [TBL] [Abstract][Full Text] [Related]
8. Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Ledger WL; Fauser BC; Devroey P; Zandvliet AS; Mannaerts BM Reprod Biomed Online; 2011 Aug; 23(2):150-9. PubMed ID: 21665541 [TBL] [Abstract][Full Text] [Related]
9. Corifollitropin alfa: a new option to treat female infertility. de Lartigue J Drugs Today (Barc); 2011 Aug; 47(8):583-90. PubMed ID: 21850281 [TBL] [Abstract][Full Text] [Related]
10. A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. Corifollitropin Alfa Dose-finding Study Group Hum Reprod; 2008 Nov; 23(11):2484-92. PubMed ID: 18684735 [TBL] [Abstract][Full Text] [Related]
11. Single-chain bifunctional vascular endothelial growth factor (VEGF)-follicle-stimulating hormone (FSH)-C-terminal peptide (CTP) is superior to the combination therapy of recombinant VEGF plus FSH-CTP in stimulating angiogenesis during ovarian folliculogenesis. Trousdale RK; Pollak SV; Klein J; Lobel L; Funahashi Y; Feirt N; Lustbader JW Endocrinology; 2007 Mar; 148(3):1296-305. PubMed ID: 17122074 [TBL] [Abstract][Full Text] [Related]
12. Corifollitropin alfa: a novel long-acting recombinant follicle-stimulating hormone agonist for controlled ovarian stimulation. Loutradis D; Vlismas A; Drakakis P Womens Health (Lond); 2010 Sep; 6(5):655-64. PubMed ID: 20887164 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of results obtained with corifollitropin alfa after poor ovarian response in previous cycle using recombinant follicular stimulating hormone in the long-term protocol. Salgueiro LL; Rolim JR; Moura BR; Machado SP; Haddad C JBRA Assist Reprod; 2016 Aug; 20(3):123-6. PubMed ID: 27584604 [TBL] [Abstract][Full Text] [Related]
14. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
15. Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation. de Greef R; Zandvliet AS; de Haan AF; Ijzerman-Boon PC; Marintcheva-Petrova M; Mannaerts BM Clin Pharmacol Ther; 2010 Jul; 88(1):79-87. PubMed ID: 20520605 [TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in-vivo. Ono C; Yamada M; Tanaka M J Pharm Pharmacol; 2003 Dec; 55(12):1647-54. PubMed ID: 14738591 [TBL] [Abstract][Full Text] [Related]
17. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
18. LAPS-FSH: a new and effective long-acting follicle-stimulating hormone analogue for the treatment of infertility. Jung S; Park Y; Kim Y; Kim YY; Choi HJ; Son WC; Kwon S Reprod Fertil Dev; 2014 Oct; 26(8):1142-53. PubMed ID: 24044514 [TBL] [Abstract][Full Text] [Related]
19. A single-chain tetradomain glycoprotein hormone analog elicits multiple hormone activities in vivo. Garcia-Campayo V; Boime I; Ma X; Daphna-Iken D; Kumar TR Biol Reprod; 2005 Feb; 72(2):301-8. PubMed ID: 15385421 [TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]